JP2023543803A - プライム編集ガイドrna、その組成物、及びその使用方法 - Google Patents
プライム編集ガイドrna、その組成物、及びその使用方法 Download PDFInfo
- Publication number
- JP2023543803A JP2023543803A JP2023519084A JP2023519084A JP2023543803A JP 2023543803 A JP2023543803 A JP 2023543803A JP 2023519084 A JP2023519084 A JP 2023519084A JP 2023519084 A JP2023519084 A JP 2023519084A JP 2023543803 A JP2023543803 A JP 2023543803A
- Authority
- JP
- Japan
- Prior art keywords
- pegrna
- nucleotides
- napdnabp
- editing
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083067P | 2020-09-24 | 2020-09-24 | |
| US63/083,067 | 2020-09-24 | ||
| US202063091272P | 2020-10-13 | 2020-10-13 | |
| US63/091,272 | 2020-10-13 | ||
| US202163182633P | 2021-04-30 | 2021-04-30 | |
| US63/182,633 | 2021-04-30 | ||
| US202163231231P | 2021-08-09 | 2021-08-09 | |
| US63/231,231 | 2021-08-09 | ||
| PCT/US2021/052097 WO2022067130A2 (en) | 2020-09-24 | 2021-09-24 | Prime editing guide rnas, compositions thereof, and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543803A true JP2023543803A (ja) | 2023-10-18 |
| JP2023543803A5 JP2023543803A5 (cg-RX-API-DMAC7.html) | 2024-10-02 |
Family
ID=78302966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519084A Pending JP2023543803A (ja) | 2020-09-24 | 2021-09-24 | プライム編集ガイドrna、その組成物、及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230357766A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4217490A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023543803A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021350835A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3193099A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022067130A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| AU2015298571B2 (en) | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US20220259617A1 (en) | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| JP7785002B2 (ja) | 2019-11-05 | 2025-12-12 | ペアーワイズ プランツ サービシズ, インコーポレイテッド | 対立遺伝子のrnaにコードされたdnaの置換のための組成物および方法 |
| CA3177481A1 (en) | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| KR20230091894A (ko) | 2020-10-21 | 2023-06-23 | 메사추세츠 인스티튜트 오브 테크놀로지 | 부위 특이적 표적화 요소를 통한 프로그램 가능한 첨가(paste)를 사용하는 부위 특이적 유전 공학을 위한 시스템, 방법, 및 조성물 |
| AU2021374974A1 (en) * | 2020-11-06 | 2023-05-25 | Pairwise Plants Services, Inc. | Compositions and methods for rna-encoded dna-replacement of alleles |
| IL308836A (en) | 2021-05-28 | 2024-01-01 | Sana Biotechnology Inc | Lipid Particles Containing Baboon Truncated Endogenous Retrovirus (BAEV) Envelope Glycoprotein and Related Methods and Uses |
| CA3173953A1 (en) * | 2021-06-11 | 2023-12-10 | Tyson D. BOWEN | Rna polymerase iii promoters and methods of use |
| AU2022325955A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions |
| CA3227108A1 (en) | 2021-08-11 | 2023-02-16 | Xiaomeng HU | Genetically modified primary cells for allogeneic cell therapy |
| AU2022326565A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy |
| AU2022325231A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions |
| US20250313861A1 (en) | 2021-10-22 | 2025-10-09 | Sana Biotechnology, Inc. | Methods of engineering allogeneic t cells with a transgene in a tcr locus and associated compositions and methods |
| EP4448775A1 (en) | 2021-12-17 | 2024-10-23 | Sana Biotechnology, Inc. | Modified paramyxoviridae attachment glycoproteins |
| US20250059239A1 (en) | 2021-12-17 | 2025-02-20 | Sana Biotechnology, Inc. | Modified paramyxoviridae fusion glycoproteins |
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023150518A1 (en) | 2022-02-01 | 2023-08-10 | Sana Biotechnology, Inc. | Cd3-targeted lentiviral vectors and uses thereof |
| WO2023150647A1 (en) | 2022-02-02 | 2023-08-10 | Sana Biotechnology, Inc. | Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023158836A1 (en) | 2022-02-17 | 2023-08-24 | Sana Biotechnology, Inc. | Engineered cd47 proteins and uses thereof |
| WO2023192655A2 (en) * | 2022-04-01 | 2023-10-05 | Prime Medicine, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2023205694A2 (en) * | 2022-04-20 | 2023-10-26 | Tacit Therapeutics, Inc. | Stabilization of therapeutic trans-splicing rna molecules in human cells |
| WO2023215831A1 (en) * | 2022-05-04 | 2023-11-09 | Tome Biosciences, Inc. | Guide rna compositions for programmable gene insertion |
| WO2023220672A1 (en) * | 2022-05-13 | 2023-11-16 | The Regents Of The University Of California | Compositions and methods for rna editing |
| CN121826033A (zh) * | 2022-05-25 | 2026-04-10 | 中国科学院遗传与发育生物学研究所 | 一种在基因组中定点插入外源序列的方法 |
| US20250354177A1 (en) * | 2022-05-30 | 2025-11-20 | Wuhan University | System and methods for duplicating target fragments |
| US20260185068A1 (en) * | 2022-06-02 | 2026-07-02 | Univesity Of Massachusetts | High fidelity nucleotide polymerase chimeric prime editor systems |
| CN114958767B (zh) * | 2022-06-02 | 2022-12-27 | 健颐生物科技发展(山东)有限公司 | 基于hiPSC细胞构建的神经干细胞制剂的制备方法 |
| CN115948461A (zh) * | 2022-07-14 | 2023-04-11 | 五邑大学 | 一种双向导碱基基因编辑系统及其应用 |
| EP4562142A1 (en) * | 2022-07-27 | 2025-06-04 | Inscripta, Inc. | Modulating cellular repair mechanisms for genomic editing |
| CN116064517A (zh) * | 2022-07-29 | 2023-05-05 | 之江实验室 | 一种先导编辑gRNA的产生方式及其用途 |
| WO2024044655A1 (en) | 2022-08-24 | 2024-02-29 | Sana Biotechnology, Inc. | Delivery of heterologous proteins |
| WO2024064761A2 (en) * | 2022-09-20 | 2024-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions to control gene using genome editing |
| CN115948449B (zh) * | 2022-09-20 | 2026-03-27 | 浙江大学杭州国际科创中心 | 一种适用于酵母先导编辑的双质粒系统及应用 |
| EP4590688A1 (en) | 2022-09-21 | 2025-07-30 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| WO2024077267A1 (en) | 2022-10-07 | 2024-04-11 | The Broad Institute, Inc. | Prime editing methods and compositions for treating triplet repeat disorders |
| EP4602174A1 (en) | 2022-10-13 | 2025-08-20 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024086586A2 (en) * | 2022-10-18 | 2024-04-25 | Flagship Pioneering Innovations Vi, Llc | Improved gene editing systems utilizing trans recruiting components |
| WO2024097313A1 (en) | 2022-11-02 | 2024-05-10 | Sana Biotechnology, Inc. | Methods for producing t cell therapy products |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| WO2024151541A1 (en) | 2023-01-09 | 2024-07-18 | Sana Biotechnology, Inc. | Type-1 diabetes autoimmune mouse |
| US20260218188A1 (en) * | 2023-01-18 | 2026-07-30 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Antisense oligonucleotides for rna editing and methods for using the same |
| WO2024168116A1 (en) | 2023-02-08 | 2024-08-15 | Prime Medicine, Inc. | Genome editing compositions and methods for treatment of myotonic dystrophy |
| EP4662306A2 (en) | 2023-02-09 | 2025-12-17 | The Broad Institute Inc. | Evolved recombinases for editing a genome in combination with prime editing |
| WO2024170866A1 (en) * | 2023-02-16 | 2024-08-22 | Genome Research Limited | Methods for modifying a cell genome |
| WO2024206125A1 (en) * | 2023-03-24 | 2024-10-03 | The Broad Institute, Inc. | Use of prime editing for treating sickle cell disease |
| WO2024215712A2 (en) * | 2023-04-11 | 2024-10-17 | University Of Washington | Methods for identifying epigenetic factors influencing gene editing and modulating gene editing outcome via epigenetic modulation |
| WO2024220135A1 (en) | 2023-04-17 | 2024-10-24 | University Of Massachusetts | Prime editing systems having pegrna with reduced auto-inhibitory interaction |
| WO2024220598A2 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Lentiviral vectors with two or more genomes |
| EP4698666A1 (en) | 2023-04-18 | 2026-02-25 | Sana Biotechnology, Inc. | Universal protein g fusogens and adapter systems thereof and related lipid particles and uses |
| WO2024220560A1 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Engineered protein g fusogens and related lipid particles and methods thereof |
| CN121843705A (zh) | 2023-05-03 | 2026-04-10 | 萨那生物科技公司 | 工程化胰岛细胞的给药和施用方法 |
| WO2024243236A2 (en) | 2023-05-22 | 2024-11-28 | Sana Biotechnology, Inc. | Methods of delivery of islet cells and related methods |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| KR20260028193A (ko) | 2023-05-23 | 2026-03-03 | 더 브로드 인스티튜트, 인코퍼레이티드 | 개선된 에디팅 효율을 갖는 진화 및 조작된 프라임 에디터 |
| WO2025022290A1 (en) | 2023-07-21 | 2025-01-30 | Crispr Therapeutics Ag | Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene |
| WO2025038881A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Prime editing of single base mutations in sickle cell disease |
| WO2025049563A1 (en) * | 2023-08-28 | 2025-03-06 | University Of Florida Research Foundation, Inc. | A programmable gene correction technology using cas-polymerase constructs |
| EP4771154A2 (en) * | 2023-09-01 | 2026-07-08 | Renagade Therapeutics Management Inc. | Gene editing systems, compositions, and methods for treatment of vexas syndrome |
| WO2025054202A1 (en) | 2023-09-05 | 2025-03-13 | Sana Biotechnology, Inc. | Method of screening a sample comprising a transgene with a unique barcode |
| WO2025076306A1 (en) | 2023-10-06 | 2025-04-10 | University Of Massachusetts | Prime editors having improved prime editing efficiency |
| WO2025096936A2 (en) | 2023-11-03 | 2025-05-08 | The Broad Institute, Inc. | Use of prime editing in correcting mutations in cdkl5 |
| WO2025111452A2 (en) * | 2023-11-21 | 2025-05-30 | Prime Medicine, Inc. | CHEMICAL MODIFICATIONS IN PEgRNA and ngRNAs |
| KR102969401B1 (ko) * | 2023-11-21 | 2026-05-29 | 경상국립대학교산학협력단 | 교정 정밀도가 향상된 프라임 에디팅 시스템 및 이의 용도 |
| CN117497092B (zh) * | 2024-01-02 | 2024-05-14 | 微观纪元(合肥)量子科技有限公司 | 基于动态规划和量子退火的rna结构预测方法及系统 |
| WO2025151814A1 (en) | 2024-01-10 | 2025-07-17 | The Broad Institute, Inc. | Use of prime editing in correcting mutations in cftr |
| AU2025208175A1 (en) | 2024-01-12 | 2026-06-25 | Sana Biotechnology, Inc. | Safety switches to control in vitro and in vivo proliferation of cell therapy products |
| EP4600357A1 (en) * | 2024-02-12 | 2025-08-13 | Technische Universität München | Delivery system for gene editing tools |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| WO2025188921A1 (en) | 2024-03-06 | 2025-09-12 | Mdx Management Llc | Shp-1 inhibitors and activators of t cells |
| WO2025212519A1 (en) | 2024-04-01 | 2025-10-09 | Moonlight Bio, Inc. | Dll3 binding proteins and uses thereof |
| US20250313863A1 (en) * | 2024-04-09 | 2025-10-09 | Trustees Of Boston University | ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF |
| WO2025217616A1 (en) | 2024-04-12 | 2025-10-16 | The Broad Institute, Inc. | Prime editing and base editing of the atp1a3 gene for the treatment of alternating hemiplegia of childhood |
| WO2025235828A2 (en) * | 2024-05-08 | 2025-11-13 | The General Hospital Corporation | Engineered prime editors for treating genetic deafness |
| WO2025240795A1 (en) * | 2024-05-15 | 2025-11-20 | President And Fellows Of Harvard College | End-modified grnas for improved base editing |
| WO2025250677A1 (en) * | 2024-05-28 | 2025-12-04 | The Trustees Of The University Of Pennsylvania | Compositions and methods for correction of trex1 mutations |
| CN118581153A (zh) * | 2024-08-05 | 2024-09-03 | 崖州湾国家实验室 | Dna聚合酶介导的核苷酸序列编辑方法及组合物 |
| WO2026055354A2 (en) * | 2024-09-04 | 2026-03-12 | University Of Massachusetts | Prime editing with modification-tolerant polymerases |
| WO2026069163A1 (en) | 2024-09-25 | 2026-04-02 | Crispr Therapeutics Ag | Differentiation method for producing immature beta cells |
| WO2026106945A2 (en) | 2024-11-12 | 2026-05-21 | The Broad Institute, Inc. | Engineered prime editing guide rnas and methods of making and using same |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010521978A (ja) * | 2007-03-22 | 2010-07-01 | イェール ユニバーシティー | Preq1リボスイッチならびにpreq1リボスイッチの使用のための、およびpreq1リボスイッチを用いる使用のための方法および組成物 |
| JP2016533760A (ja) * | 2013-09-06 | 2016-11-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | スイッチ可能cas9ヌクレアーゼおよびその使用 |
| WO2018209320A1 (en) * | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| WO2020191153A2 (en) * | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| JP2021523739A (ja) * | 2018-05-11 | 2021-09-09 | ビーム セラピューティクス インク. | プログラム可能な塩基エディターシステムを用いて単一ヌクレオチド多型を編集する方法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663290A (en) | 1982-01-21 | 1987-05-05 | Molecular Genetics, Inc. | Production of reverse transcriptase |
| US5374553A (en) | 1986-08-22 | 1994-12-20 | Hoffmann-La Roche Inc. | DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima |
| US4889818A (en) | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
| US5079352A (en) | 1986-08-22 | 1992-01-07 | Cetus Corporation | Purified thermostable enzyme |
| US5244797B1 (en) | 1988-01-13 | 1998-08-25 | Life Technologies Inc | Cloned genes encoding reverse transcriptase lacking rnase h activity |
| US4965185A (en) | 1988-06-22 | 1990-10-23 | Grischenko Valentin I | Method for low-temperature preservation of embryos |
| US5047342A (en) | 1989-08-10 | 1991-09-10 | Life Technologies, Inc. | Cloning and expression of T5 DNA polymerase |
| US5270179A (en) | 1989-08-10 | 1993-12-14 | Life Technologies, Inc. | Cloning and expression of T5 DNA polymerase reduced in 3'- to-5' exonuclease activity |
| JP2709311B2 (ja) | 1990-09-28 | 1998-02-04 | エフ.ホフマン−ラ ロシュ アクチェンゲゼルシャフト | 熱安定性dnaポリメラーゼの5→3′のエキソヌクレアーゼ突然変異 |
| WO1992006188A2 (en) | 1990-10-05 | 1992-04-16 | Barnes Wayne M | Thermostable dna polymerase |
| US5834247A (en) | 1992-12-09 | 1998-11-10 | New England Biolabs, Inc. | Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein |
| US5496714A (en) | 1992-12-09 | 1996-03-05 | New England Biolabs, Inc. | Modification of protein by use of a controllable interveining protein sequence |
| US5436149A (en) | 1993-02-19 | 1995-07-25 | Barnes; Wayne M. | Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension |
| US5512462A (en) | 1994-02-25 | 1996-04-30 | Hoffmann-La Roche Inc. | Methods and reagents for the polymerase chain reaction amplification of long DNA sequences |
| US5912155A (en) | 1994-09-30 | 1999-06-15 | Life Technologies, Inc. | Cloned DNA polymerases from Thermotoga neapolitana |
| US5614365A (en) | 1994-10-17 | 1997-03-25 | President & Fellow Of Harvard College | DNA polymerase having modified nucleotide binding site for DNA sequencing |
| US5773258A (en) | 1995-08-25 | 1998-06-30 | Roche Molecular Systems, Inc. | Nucleic acid amplification using a reversibly inactivated thermostable enzyme |
| US6183998B1 (en) | 1998-05-29 | 2001-02-06 | Qiagen Gmbh Max-Volmer-Strasse 4 | Method for reversible modification of thermostable enzymes |
| GB9920194D0 (en) | 1999-08-27 | 1999-10-27 | Advanced Biotech Ltd | A heat-stable thermostable DNA polymerase for use in nucleic acid amplification |
| JP2003514564A (ja) | 1999-11-24 | 2003-04-22 | エムシーエス マイクロ キャリア システムズ ゲーエムベーハー | 核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法 |
| US8178291B2 (en) | 2005-02-18 | 2012-05-15 | Monogram Biosciences, Inc. | Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors |
| US9783791B2 (en) | 2005-08-10 | 2017-10-10 | Agilent Technologies, Inc. | Mutant reverse transcriptase and methods of use |
| CN101668848B (zh) | 2007-04-26 | 2014-10-22 | 雷蒙特亚特特拉维夫大学有限公司 | 来自口腔粘膜的多能自体干细胞和使用方法 |
| EP3199630B1 (en) | 2008-09-05 | 2019-05-08 | President and Fellows of Harvard College | Continuous directed evolution of proteins and nucleic acids |
| JP5882064B2 (ja) | 2009-03-04 | 2016-03-09 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 安定化された逆転写酵素融合タンパク質 |
| US8889394B2 (en) | 2009-09-07 | 2014-11-18 | Empire Technology Development Llc | Multiple domain proteins |
| PT2816112T (pt) | 2009-12-10 | 2018-11-20 | Univ Iowa State Res Found Inc | Modificação do adn modificada pelo efector tal |
| WO2012054727A1 (en) | 2010-10-22 | 2012-04-26 | Bio-Rad Laboratories, Inc. | Reverse transcriptase mixtures with improved storage stability |
| EP3202903B1 (en) | 2010-12-22 | 2020-02-12 | President and Fellows of Harvard College | Continuous directed evolution |
| US9200045B2 (en) | 2011-03-11 | 2015-12-01 | President And Fellows Of Harvard College | Small molecule-dependent inteins and uses thereof |
| JP6177780B2 (ja) | 2011-09-28 | 2017-08-09 | エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. | スプリットインテインおよびその使用 |
| PT2877490T (pt) | 2012-06-27 | 2019-02-12 | Univ Princeton | Inteínas clivadas, conjugados e suas utilizações |
| US9181535B2 (en) | 2012-09-24 | 2015-11-10 | The Chinese University Of Hong Kong | Transcription activator-like effector nucleases (TALENs) |
| US10047352B2 (en) | 2012-10-03 | 2018-08-14 | Agrivida, Inc. | Intein-modified proteases, their production and industrial applications |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| EP3097196B1 (en) | 2014-01-20 | 2019-09-11 | President and Fellows of Harvard College | Negative selection and stringency modulation in continuous evolution systems |
| DK3212778T3 (da) | 2014-10-28 | 2019-11-04 | Agrivida Inc | Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser |
| US11299729B2 (en) | 2015-04-17 | 2022-04-12 | President And Fellows Of Harvard College | Vector-based mutagenesis system |
| EP4431607A3 (en) * | 2016-09-09 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | High-throughput precision genome editing |
| US9580698B1 (en) | 2016-09-23 | 2017-02-28 | New England Biolabs, Inc. | Mutant reverse transcriptase |
| US10011849B1 (en) * | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US11268092B2 (en) * | 2018-01-12 | 2022-03-08 | GenEdit, Inc. | Structure-engineered guide RNA |
| CA3177481A1 (en) * | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
-
2021
- 2021-09-24 CA CA3193099A patent/CA3193099A1/en active Pending
- 2021-09-24 US US18/028,183 patent/US20230357766A1/en active Pending
- 2021-09-24 EP EP21795122.7A patent/EP4217490A2/en active Pending
- 2021-09-24 JP JP2023519084A patent/JP2023543803A/ja active Pending
- 2021-09-24 AU AU2021350835A patent/AU2021350835A1/en active Pending
- 2021-09-24 WO PCT/US2021/052097 patent/WO2022067130A2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010521978A (ja) * | 2007-03-22 | 2010-07-01 | イェール ユニバーシティー | Preq1リボスイッチならびにpreq1リボスイッチの使用のための、およびpreq1リボスイッチを用いる使用のための方法および組成物 |
| JP2016533760A (ja) * | 2013-09-06 | 2016-11-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | スイッチ可能cas9ヌクレアーゼおよびその使用 |
| WO2018209320A1 (en) * | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| JP2021523739A (ja) * | 2018-05-11 | 2021-09-09 | ビーム セラピューティクス インク. | プログラム可能な塩基エディターシステムを用いて単一ヌクレオチド多型を編集する方法 |
| WO2020191153A2 (en) * | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
Non-Patent Citations (2)
| Title |
|---|
| ANZALONE, A.V., ET AL.: ""Search-and replace genome editing without double-strand breaks or donor DNA."", NATURE, vol. 576, JPN6025005927, 5 December 2019 (2019-12-05), pages 149 - 157, ISSN: 0005852867 * |
| KIM, H.K., ET AL.: ""Predicting the efficiency of prime editing guide RNAs in human cells."", NATURE BIOTECHNOLOGY, vol. 39, no. 2, JPN6025038113, 21 September 2020 (2020-09-21), pages 198 - 206, ISSN: 0005852868 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230357766A1 (en) | 2023-11-09 |
| AU2021350835A1 (en) | 2023-04-27 |
| WO2022067130A2 (en) | 2022-03-31 |
| EP4217490A2 (en) | 2023-08-02 |
| WO2022067130A3 (en) | 2022-06-23 |
| CA3193099A1 (en) | 2022-03-31 |
| AU2021350835A2 (en) | 2023-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114127285B (zh) | 编辑核苷酸序列的方法和组合物 | |
| US12031126B2 (en) | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence | |
| US20230357766A1 (en) | Prime editing guide rnas, compositions thereof, and methods of using the same | |
| JP2022526908A5 (cg-RX-API-DMAC7.html) | ||
| JP2022532470A5 (cg-RX-API-DMAC7.html) | ||
| JP2022527740A5 (cg-RX-API-DMAC7.html) | ||
| WO2020086908A1 (en) | Constructs for improved hdr-dependent genomic editing | |
| CN116685682A (zh) | 引导编辑向导rna、其组合物以及使用它们的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240924 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240924 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250912 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20251006 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20251006 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251125 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260212 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260311 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260507 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260807 |